Hungarian Cancer Drug to Bring a Potential Breakthrough in Treatment [Video]

The proteins in tumor cells are attacked by a molecule that could later form the basis of a new drug. This targeted therapy could be a breakthrough in the treatment of melanoma, as well as pancreatic and breast cancer, if clinical trials at the National Institute of Oncology are successful. The institute has been carrying out research for many years, in addition to providing innovative therapeutic solutions and acting as a training center. All this is a prerequisite for the Comprehensive Cancer Center accreditation, which was awarded for the fourth time to the region’s leading oncology institution.

Prof. Dr. Csaba Polgár, the Director General of the National Institute of Oncology spoke in an interview with Index about when the Hungarian drug will be ready and the National Institute of Oncology as an accredited Comprehensive Cancer Center.

“Currently, we have promising results in melanoma, breast cancer and pancreatic cancer,” the expert started. Following clinical trials, the new …